| CRDF Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CRDF market cap history going back to 4/30/2020:
Also see: CRDF Shares Outstanding History and CRDF YTD Return |
CRDF Market Cap History — Cardiff Oncology Capitalization Over Time
As of 8/6/2026 Cardiff Oncology has a market cap of 74.68 million. Investors often follow the CRDF market cap history to compare the size of the company over time.
This page shows CRDF market capitalization trends over time, with 26 market cap datapoints presented, dating back to 4/30/2020.
| CRDF Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
CRDF Historical Market Cap: +28.82% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CRDF Stock Price Chart |
| About Cardiff Oncology Inc |
| Cardiff Oncology, Inc. is a clinical-stage biotechnology company. It is leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the unmet medical need. It is focused on clinical programs in indications, such as RAS-mutated metastatic colorectal cancer (mCRC), and in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), and triple negative breast cancer (TNBC). Its lead drug candidate, Onvansertib, is an oral, small molecule drug candidate that is highly specific for PLK1 inhibition with a 24-hour half-life. We show 26 historical shares outstanding datapoints in our CRDF shares outstanding history coverage, used to compute CRDF market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CRDF market cap history over the course of time is important for investors interested in comparing CRDF's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CRDF versus a peer is one thing; comparing CRDF market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CRDF can fluctuate over the course of history. With this page we aim to empower investors researching CRDF by allowing them to research the CRDF market cap history. |
| CRDF Current Stock Quote |
Quotes delayed 20 minutes  Free CRDF Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CRDF Share Performance |
| Market Cap Peers |
| Cardiff Oncology (CRDF) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CRGX Market Cap History CRH Market Cap History CRIS Market Cap History CRL Market Cap History CRMD Market Cap History CRNX Market Cap History CRTX Market Cap History CRVL Market Cap History CRVO Market Cap History CRVS Market Cap History More Healthcare companies » |
CRDF Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
